InsidersTradesSigma
Discover the full record of transactions filed by Rummelt Andreas, Director. Director active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 4 filings have been published. The latest transaction was disclosed on 21 July 2021 — Disposition. Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Andreas Rummelt is a Board Member at Alexion Pharmaceuticals, Inc., a company specializing in innovative therapies for rare diseases. As a board member, he participates in the governance of the company and in shaping its strategy. His expertise in the pharmaceutical sector is a valuable asset for Alexion in its mission to improve patients' lives.